Targeted immunotherapy in acute myeloblastic leukemia : from animals to humans
Targeted immunotherapy in acute myeloblastic leukemia : from animals to humans
About this item
Full title
Author / Creator
Publisher
Berlin: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Scope and Contents
Contents
Immunity against acute myeloid leukemia (AML) is demonstrated in humans by the graft-versus-leukemia effect in allogeneic hematopoietic stem cell transplantation. Specific leukemic antigens have progressively been discovered and circulating specific T lymphocytes against Wilms tumor antigen, proteinase peptide or fusion-proteins produced from aberr...
Alternative Titles
Full title
Targeted immunotherapy in acute myeloblastic leukemia : from animals to humans
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11034191
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11034191
Other Identifiers
ISSN
0340-7004
E-ISSN
1432-0851,1365-2567
DOI
10.1007/s00262-005-0678-1
